Management of Dementia of Alzheimer’s type (DAT) with Medhya Rasayana Churna Pallavi A. Ghadage Assistant professor, Department of Kayachikitsa, Late Kedari Redekar Ayurveda Mahavidyalaya and Hospital, Gadhinglaj, Maharashtra Kshama Gupta Professor, Department of Kayachikitsa, R. B. Ayurvedic Medical College and Hospital, Agra, Uttar Pradesh, India Niranjan Y Professor & Head, Department of Kayachikitsa, Indian Institute of Ayurveda Research and Hospital, Rajkot, Gujarat, India Keywords: Ayurveda, Dementia of Alzheimer’s type, Medhya Rasayana Abstract Dementia of Alzheimer’s type (DAT) is a progressive inevitable loss of cognitive function associated with the manifestation of senile plaques in the hippocampal area of the brain. It is most common form of dementia among middle age and older adults which accounts for 60-80 percent of dementia cases. The pathogenesis of DAT can be multifactorial. An open clinical trial was conducted to evaluate the efficacy of Medhya Rasayana in clinically diagnosed 11 patients of Dementia of Alzheimer’s type (DAT) belonging to the age group of 50-80 years. The trial drug Medhya Rasayana churna administered 5gm in divided dose twice in a day with Madhu and Ghrita in unequal quantity for twelve weeks. Effect of therapy was assessed by Manas Bhava, Agnibala, Dehabala and Satvabala Pariksha. Statistically significant improvement observed in outcome measures. pdf Published 2021-12-25 Issue Vol 5 No 4 (2021): October- December 2021 Section Short Communication
